TY - JOUR
T1 - Platelet function changes in patients undergoing endovascular aortic aneurysm repair
T2 - Review of the literature
AU - Burban, Anna
AU - Idzik, Aleksandra
AU - Gelo, Agata
AU - Filipiak, Krzysztof J.
AU - Jakimowicz, Tomasz
AU - Jama, Katarzyna
AU - Grabowski, Marcin
AU - Gasecka, Aleksandra
AU - Siniarski, Aleksander
N1 - Funding Information: Figures have been created with BioRender.com, licensed version purchased by AGa. Publisher Copyright: Copyright © 2022 Burban, Idzik, Gelo, Filipiak, Jakimowicz, Jama, Grabowski, Gasecka and Siniarski.
PY - 2022/8/12
Y1 - 2022/8/12
N2 - Patients with abdominal aortic aneurysm (AAA) have a higher risk of cardiovascular (CV) events, which seems to be associated with disturbed platelet (PLT) function. Endovascular aneurysm repair (EVAR) is an emerging, less-invasive treatment alternative to surgical AAA repair. Both platelet function abnormalities in patients with AAA and the effect of EVAR on platelet function are poorly understood. In this review, we aim to fill the gap regarding the effect of EVAR on PLT function in AAA patients by discussing PLT function disturbances in patients with AAA, PLT function changes after EVAR, evidence from clinical studies regarding PLT function before and after EVAR, and antiplatelet or and antithrombotic treatment in patients undergoing EVAR. The goal of our review is to summarize the contemporary knowledge and initiate further studies to better understand PLT function changes in patients undergoing EVAR, optimize the pharmacotherapy before and after EVAR and further improve outcomes in this group of patients.
AB - Patients with abdominal aortic aneurysm (AAA) have a higher risk of cardiovascular (CV) events, which seems to be associated with disturbed platelet (PLT) function. Endovascular aneurysm repair (EVAR) is an emerging, less-invasive treatment alternative to surgical AAA repair. Both platelet function abnormalities in patients with AAA and the effect of EVAR on platelet function are poorly understood. In this review, we aim to fill the gap regarding the effect of EVAR on PLT function in AAA patients by discussing PLT function disturbances in patients with AAA, PLT function changes after EVAR, evidence from clinical studies regarding PLT function before and after EVAR, and antiplatelet or and antithrombotic treatment in patients undergoing EVAR. The goal of our review is to summarize the contemporary knowledge and initiate further studies to better understand PLT function changes in patients undergoing EVAR, optimize the pharmacotherapy before and after EVAR and further improve outcomes in this group of patients.
KW - EVAR
KW - abdominal aortic aneurysm
KW - coagulation
KW - endovascular AAA repair
KW - hemostasis
KW - platelets
UR - http://www.scopus.com/inward/record.url?scp=85136818174&partnerID=8YFLogxK
U2 - https://doi.org/10.3389/fcvm.2022.927995
DO - https://doi.org/10.3389/fcvm.2022.927995
M3 - Review article
C2 - 36035918
VL - 9
JO - Frontiers in Cardiovascular Medicine
JF - Frontiers in Cardiovascular Medicine
SN - 2297-055X
M1 - 927995
ER -